Cargando…
BMI-1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor
Endometrial adenocarcinoma is one of the most common types of gynecological malignancies and its incidence and mortality rates are increasing. Due to tumor recurrence and metastasis, the overall five-year survival rate of patients with endometrial adenocarcinoma is shortened. The aim of the present...
Autores principales: | Yu, Jing, Chen, Ling, Bao, Zhenhua, Liu, Ying, Liu, Guohong, Li, Fengling, Li, Lianqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108087/ https://www.ncbi.nlm.nih.gov/pubmed/32323819 http://dx.doi.org/10.3892/or.2020.7539 |
Ejemplares similares
-
BMI-1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor
por: Yu, Jing, et al.
Publicado: (2022) -
MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro
por: Li, Fengling, et al.
Publicado: (2017) -
Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer
por: Guo, Bao-Hong, et al.
Publicado: (2011) -
BMI1 induces an invasive signature in melanoma that promotes metastasis and chemoresistance
por: Ferretti, Roberta, et al.
Publicado: (2016) -
Bmi-1 Immunohistochemical Expression in Endometrial Carcinoma is Correlated with Prognostic Activity
por: Horie, Kayo, et al.
Publicado: (2020)